HX301

· Hangzhou Hanx Biopharmaceuticals, Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HX301, covering 2025-01-15 to 2025-01-15. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2 Study of HX301 in Patients with High-grade Giloma [Phase 1, Phase 2]